CIRM’s Education and Training programs are a vital link to tomorrow. The California Institute for Regenerative Medicine (CIRM) offers invaluable educational and training pathways in regenerative ...

CIRM’s core programs focus on critical areas that drive the development and commercialization of regenerative medicine treatments. Spanning education, research, and funding opportunities, these ...

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

A comprehensive review has explored the diverse roles of extracellular vesicles (EVs) in the oral and maxillofacial region, ...

FORT LAUDERDALE, FL / ACCESSWIRE / February 11, 2025 / ZEO ScientifiX, Inc. ('ZEO' or the 'Company') (OTCQB:ZEOX), a clinical-stage biopharmaceutical company fo ...

FORT LAUDERDALE, FL / ACCESS Newswire / February 11, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on the research and developme ...

Exosomes, naturally occurring extracellular vesicles, have garnered increasing interest in the field of cosmetics and skincare due to their regenerative pr | Drug Discovery And Development ...

New blinded preliminary BRTX-100 data described this past Saturday at prestigious "2025 Winners in Industry Innovations in MSK Health” presentation - - Among other positive preliminary data analyses, ...

Salmon sperm, spicules, and exosomes—oh my! K-beauty has served as a north star in the skin care industry for over a decade ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

Exosomes are gaining recognition for their potential applications in medicine, particularly in wound healing and inflammation reduction.

The world of aesthetic tweakments is no longer dominated by muscle-relaxing injections and filler. No, no; these days, there ...